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ABSTRACT 
Kinetic studies and chemical modification studies were performed on malate 
dehydrogenase from Escherichia coli (eMDH). Chemical modification studies using 
diethylpyrocarbonate and iodoacetic acid, along with log V/K profiles indicate that one 
ionizing group with a pKa between 7. 9 and 8. 5 acts as a general acid/base in the catalytic 
mechanism. Log V profiles suggest that malate binds to the correctly protonated form 
of the enzyme. These results imply that a histidine residue is required for catalysis. 
A primary deuterium kinetic isotope effect of 1.43 (±0.14) was observed on V/K 
using malate-2-d, while no isotope effect was measured on V maX" This implies that proton 
abstraction is partially rate determining under nonsaturating conditions. Small isotope 
effects were observed on V max and V /K ( 1. 22 ± 0 .19 and 1. 08 ± 0. 06) when using 
NADD, indicating that the rate determining step is the release of the cofactor. 
Other kinetic studies show that eMDH is inhibited by the substrates oxaloacetate 
and NADH at high concentrations. Through substrate analog inhibition experiments, 
using citrate, malonate, ketomalonate and ATP, it was found that eMDH is very specific 
for it substrates. 
Allosteric interactions between ligand and substrate provide a means of regulation, 
since they allow the activity of an enzyme to be controlled by changes in the 
concentrations of other species (including the products). It was determined that eMDH 
is allosterically inhibited in the presence of 0.065 mM NADH 
Other chemical modification reagents specific for arginine residues such as, 1, 2-
cyclohexanedione, indicate that arginine residues are important for catalysis and most 
likely play a role in binding the substrate. 
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Chapter I 
INTRODUCTION 
Most every reaction that occurs in the cell is catalyzed by its own particular 
enzyme. In bacterial cells, such as Escherichia coli, it is estimated that there are 
3,000 different proteins. In higher eukaryotic cells there are 50,000 proteins, the 
majority of which are enzymes. In the absence of enzymes, most of the reactions that 
occur in the cell would not occur even over a time period of years, and life as we 
know it would not exist. Thus, ·the ultimate goal of enzyme studies is to gain an 
understanding of the crucial role that these catalysts play in the metabolism of living 
organisms. 
Enzymes are biological catalysts that increase the rate of chemical reactions 
without undergoing a permanent change themselves. Enzyme catalysis is usually 
comprised of three basic steps: 1) The substrates (reactants) bind to the enzyme in a 
specific order to form an enzyme-substrate complex. 2) Due to the catalytic activity 
of certain amino acid residues located in the active site, the substrates are converted 
to products. 3) The products then dissociate from the enzyme. 
Enzymes display four remarkable characteristics; 1) high catalytic power, 2) 
mild reaction conditions, 3) great specificity, and 4) the capacity for regulation. 
The rate of an enzyme catalyzed reaction may be as much as 1014 fold greater 
than the non-catalyzed reaction. Enzyme catalyzed reaction rates are typically 106 to 
1012 greater than uncatalyzed reactions, and are several orders of magnitude greater 
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than the corresponding chemically catalyzed reactions. Furthermore, enzymatically 
catalyzed reactions occur under mild conditions; temperatures less than 100°C, 
atmospheric pressure and neutral pH, in contrast to chemical catalysis which usually 
requires elevated temperatures and pressures as well as extremes of pH. 
Enzymes show great specificity with respect to both substrates and products. 
There are some enzymes that have low specificity; they will utilize a wide range of 
substrates as long as they contain the required chemical bond. A second class of 
enzymes exhibit group specificity; they will catalyze the reactions of a variety of 
similar molecules. The last group of enzymes show near-absolute specificity or 
absolute specificity. These enzymes will catalyze a reaction of a single substrate. 
Also, it should be noted that enzymes display distinct stereospecific requirements. 
This stereospecificity, by virtue of the inherent chirality (enzymes are comprised of 
only L-amino acids), happens due to enzymes forming asymmetric active sites. 
The fourth important property of enzymes is that their catalytic activity may be 
regulated by substances such as small ions or molecules as well as the substrate(s). 
These regulatory processes include allosteric control, covalent modification, and the 
amount of enzyme synthesized [1]. 
A fundamental problem in enzymology is the determination of the enzymatic 
mechanism, and how to account for their astonishingly high and specific catalytic 
activity based on the chemical structure of the enzyme. Enzymes may be studied by a 
variety of biological, chemical and physical means, the most classical of which is 
kinetic study, which can be regarded as essential [ 11]. Inferences of the enzymatic 
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mechanism may be drawn from varying the substrate concentration, pH, ionic 
strength, and temperature. However, it should be noted that it is not possible to 
definitively determine how an enzyme works in chemical terms without a knowledge 
of the enzyme's kinetics [ 1]. 
Kinetic measurements and chemical studies of enzymatically catalyzed 
reactions are among the most powerful tools for elucidating the catalytic mechanisms 
of enzyme reactions. Therefore, the remainder of this chapter is devoted to 
describing the kinetic and chemical tools used in the determination of the enzymatic 
mechanism of eMDH. 
The initial velocity equation for a two substrate reaction is:· 
When one of the substrate concentrations is varied and the other is fixed at a 
saturating level, the two substrate equation is simplified into the Michaelis-Menten 
equation: 
v = VA/ (Km + A) (2) 
where A is the substrate concentration and Km is the Michaelis constant [ 14]. 
There are many methods or tools available to the enzymologist which can be 
used to study the kinetic and chemical mechanisms of enzymes. In this study, many 
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classical tools such as inhibition experiments, isotope effects, and chemical 
modification experiments were employed. 
Isotope effects were used to determine the rate limiting steps of the reaction. 
The catalytic group required for activity and the pK of that catalytic group was 
determined by the use of pH variation studies. Chemical modification studies were 
used to probe for the identity of the catalytic group in the active site and were also 
used to determine the role of other amino acid residues located in the catalytic site. 
In the initial phase of enzyme study, it is important to be able to determine the 
kinetic order of a reaction. The kinetic order of an enzyme catalyzed reaction may 
vary considerably depending on the conditions. This may be demonstrated by an 
investigation of three kinetic experiments in which the enzyme concentration is held 
constant, but the initial substrate concentration is varied from low to high 
concentrations. If the initial substrate concentration is low, the reaction may appear 
to be a first-order process with respect to substrate loss. If the initial substrate 
concentration is high, the reaction rate is independent of substrate concentration which 
is a zero-order process. However, if the substrate is present in an intermediate 
concentration, the rate of conversion of substrate to product may be neither first-order 
nor zero-order. Thus, under the given set of conditions it may become very difficult 
to determine the rate law for the enzyme catalyzed reaction. 
In order to avoid these difficulties, enzyme catalyzed reactions are generally 
conducted by measuring the initial velocities. Plotting substrate concentration versus 
time usually yields straight lines for the first 10 to 20% of the total reaction. The 
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slope of the line is equal to the initial velocity, which is a zero-order rate constant 
[12, 13]. 
In the second phase of enzyme study, the kinetic mechanism is determined. 
Generally, a mathematical model is developed based on the kinetic study to describe 
the kinetic mechanism. For a two substrate reaction, there are two general types of 
kinetic models. The first is a double displacement, or ping pong mechanism in which 
one or more products must be released before all substrates can react. The second 
model is a sequential mechanism, in which all reactants must combine with the 
enzyme prior to reaction. The sequential mechanism can be further subdivided into 
an ordered or random mechanism. In the ordered mechanism, the substrates combine 
and dissociate in a specific order. However, in the random mechanism the order of 
combination and dissociation is not obligatory [12]. 
The type of inhibition (product inhibition) shown by the products P and Q 
towards the substrates A and B can be used to propose a mechanism for the reaction 
(Scheme I). In the random mechanism, Q acts as a competitive inhibitor with respect 
to substrate B. Whereas in the ordered mechanism, Q acts as a mixed-type inhibitor 
with respect to substrate B. Thus, product inhibition can be used to distinguish 
between the ordered and random ternary complex by studying the inhibition caused by 
the product Q [ 1] . 
Isotope effect experiments can be used to aid in the determination of the rate-
limiting step(s) of a reaction. There are two uses of isotope effects: 1) From the 
absolute values for the bond-breaking steps, clues of the chemical mechanism, and the 
5 
A 
E 
B p Q 
EA (EAB ~ )to EPQ) EQ 
A=NADH 
B = Oxaloacetate 
P = Malate 
Q=NAD+ 
Scheme I. The kinetic Mechanism of eMDH. 
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nature of the transition states may be ascertained. 2) The degree to which the 
absolute value is expressed in V or V /K tells where the rate limiting steps are in the 
mechanism. For a non-enzymatically catalyzed chemical reaction a full isotope effect 
is generally seen since the bond-breaking reaction is commonly rate determining. 
However, for an enzyme catalyzed reaction, steps other than the catalytic step are 
often partially rate determining. Therefore, the observed isotope effect is usually 
smaller than the true isotope effect on the bond-breaking step. If a normal hydrogen 
atom is replaced with a deuterium atom, the breakage of the carbon-deuterium bond is 
slower than that of a carbon-hydrogen bond and therefore an isotope effect is 
observed. Isotope effects are usually expressed as k8 /k0 and usually range from 5 to 
15 for deuterium. 
By using pH variations of the kinetic parameters, it is possible to determine 
which amino acid residues play a role in catalysis. The parameters of interest which 
may change with pH are V and V /K for each substrate. V can be defined as the 
maximum velocity of the reaction. K is V /2 and is also a measure of the affinity of 
the enzyme for its substrates. The Michaelis constants (K) of the substrates are of no 
interest since they are merely the ratio of V and V /K. These parameters are generally 
plotted as log V or log V/K vs. pH, thus any drop on the graph corresponds to a 
lower rate or lessened binding. Because these are log-log plots, they consist of 
straight lines with a whole number slope, which are connected by a curve that spans 
two pH units. From these plots, an estimation of the pKa of the amino acid residue(s) 
and the number of groups that participate in catalysis may be determined. 
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The biological, chemical, and physical properties of proteins can be altered by 
chemical modifying reagents. The underlying principle of chemical modification is 
extremely simple. If an amino acid residue involved in catalysis is chemically 
modified, there will be a decrease in enzyme activity. Thus, the roles of the 
individual amino acid side chains may be determined by chemically modifying the 
amino acid residues in the active site. 
Chemical modification poses one major problem, unspecific modification. 
Ideally, it is highly desirable that the modifying agent be specific for only one type of 
side chain and that only one of these amino acid side chains will have reacted. 
Therefore, any change in catalytic activity can be attributed to the modification. 
When changes in activity correspond to the modification of only one residue, it is 
unlikely that the loss of activity is due to a conformational change. This also implies 
that if there is no effect on catalytic activity, the modified residue(s) is not essential 
for the activity under investigation. 
As stated earlier, when one substrate is varied and the other is fixed at 
saturating levels, the enzyme is expected to follow equation 2. However, in substrate 
inhibition, v only increases to a certain point and decreases at higher concentrations of 
A [14]. 
Many inhibitors are substances that structurally resemble the substrates, and 
typically react slowly or not at all. Inhibitors are commonly used to probe the 
chemical and conformational nature of the active site in an effort to determine the 
enzyme's catalytic mechanism. By varying one substrate, fixing the other, and fixing 
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the inhibitor concentration, inhibition patterns can be determined. Three basic types 
of inhibition are observed: competitive, noncompetitive (or mixed inhibition), and 
uncompetitive. 
The first is competitive inhibition, which is characterized by slopes that are 
affected by an inhibitor, intercepts that are not, and a point of intersection on the 
vertical axis. This pattern indicates mutually exclusive binding of inhibitor and 
substrate to the same form of the enzyme. The second inhibition pattern is a series of 
parallel lines in which the intercepts are affected, but the slopes are not, and is 
characteristic of uncompetitive inhibition. This pattern demonstrates that the 
inhibition disappears as the substrate concentration is extrapolated to zero, and 
indicates that the enzyme form with which the inhibitor binds is not present when the 
variable substrate concentration is zero. The third form of inhibition is 
noncompetitive or mixed competition, where both the slopes and the intercepts are 
affected by inhibitor concentration. This pattern indicates that inhibitor and substrate 
bind to different forms of the enzyme and that the inhibitor can cause inhibition at 
very low or high substrate concentration. 
One of the incredible characteristics of enzyme catalysis and thereby 
metabolism is the high degree of regulation. Allosterism, which is a form of 
regulation, is the cooperative interaction of one ligand (substrate) binding to a specific 
(active) site which is influenced by the binding of an effector ligand at an allosteric 
site on the enzyme. An allosteric effect is characterized by a sigmoidal curve in a 
plot of rate vs. [substrate]. 
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A class of enzymes known as dehydrogenases catalyze the conversion of an 
alcohol to a keto-group. This study focused on malate dehydrogenase which catalyzes 
the oxidation of malate to oxaloacetate with the subsequent reduction of NAD+ to 
NADH (Scheme II) and can be found in a variety of organisms. The equilibrium of 
this reaction is in favor of malate/NAD+ by a factor of 105 . 
Malate dehydrogenase is found as the cytosolic and mitochondrial isozymes in 
eukaryotic organisms. The cytosolic form participates in the aspartate/malate shuttle, 
the function of which is to transfer cytosolic reducing equivalents across the 
mitochondrial membrane. Mitochondrial MDH participates on the other side of the 
aspartate/malate shuttle and also catalyzes the final step of the TCA cycle. The 
eukaryotic isozymes of MDH have been extensively studied and their chemical and 
physical properties have been well defined [2]. In most cases, the reaction catalyzed 
by the dimeric forms of MDH has been proposed to follow an sequential ordered Bi-
Bi mechanism with the cofactor binding before the substrate [2-6]. However, the 
prokaryotic forms of MDH have been much less studied. Kinetic studies were 
performed by Sanwall in which it was determined that eMDH is allosterically 
regulated [7]. Murphey et al. described some of the physical properties of eMDH 
[8]. Recently, the crystal structure of eMDH was elucidated in the presence of 
citrate, a substrate analog, and NAD+ [9, 10]. 
In the past 30 years much research has been conducted on lactate 
dehydrogenase, mitochondrial malate dehydrogenase, and cytosolic malate 
dehydrogenase. Thus determining that all of the above enzymes are homologous, and 
10 
OH 
-02c co2- Mal ate 
H 
NAD+ 
:MDH 
NADH+H+ 
0 
Oxaloacetate 
(OAA) 
Scheme II. The reaction catalyzed by eMDH. 
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that there is an invariant histidine residue in the active site of all three enzymes [15, 
16]. 
Site directed mutagenesis studies on LDH and mMDH indicate that both 
enzymes have a histidine located in the active site which interacts with an aspartate, 
and have proton-donating and accepting capabilities [17, 18]. Furthermore, a 
comparison of x-ray crystal structure of cMDH and LDH indicate a HisAsp pair 
which may function as a proton relay system during catalysis [ 19]. 
The crystal structure of MDH from Escherichia coli strain HB 101, indicates 
that eMDH is closely homologous with mMDH. Research has determined that E. coli 
MDH is a dimeric enzyme, and that Hisl 77 which is located in the active site, is 
found to be hydrogen bonded to an aspartate to form a classic HisAsp pair [19, 10]. 
A crystal structure, if available, is an excellent foundation for enzymatic study. 
However, as stated earlier, a crystal structure alone is not enough for the proposal of 
an enzymatic mechanism. Based on the information gleaned from the site-directed 
mutagenesis studies and from the crystal structure, an investigation of the importance 
of the invariant histidine residue (Hl 77 in eMDH), which is proposed to be involved 
in catalysis was carried out by chemical modification. 
The chemical modifying agent, diethylpyrocarbonate, reacts with the imidazole 
ring of histidine to yield a N-carbethoxyhistidyl derivative. This reaction may be 
conveniently followed spectrophotometrically by the increase in absorbance between 
230 and 250 nm [20, 21]. The number of modified residues can be calculated from 
the molar absorption difference for N-carbethoxyhistidine at 240 nm: E240 nm = 3200 
12 
M- 1 cm- 1 [20]. Hydroxylamine removes the carbethoxy group from N-
carbethoxyhistidyl residues [22]. The inactivation of an enzyme by DEPC may be 
correlated with the modification of a histidyl residue if treatment with hydroxylamine 
reactivates the enzyme [23]. The selective reaction of DEPC with imidazole groups 
and the ease with which this reaction can be quantitated, makes it a convenient probe 
for determining the accessibility and function of histidine residues. 
Haloacetates, such as iodoacetate, are the most widely used protein alkylating 
agents. Under various conditions, they have been shown to react with sulfhydryl, 
imidazole, thioether, and amino groups of proteins. In several enzymes, histidine 
residues have been shown to have an unusually high reactivity, considerably more 
than even the imidazole group of histidine itself. At pH 5. 5 and slightly above, 
imidazole groups are at least partially unprotonated, and their modification is fast 
enough to be the principle reaction in proteins lacking sulfhydryl groups [24]. 
Chemical modification studies have been conducted on porcine heart and 
bovine mMDH using iodoacetamide. The results of these studies were that a histidine 
was chemically modified, and that the histidine residue can be protected from 
modification by the presence of NADH in both cases. The results of protection 
against modification by NADH indicate that the histidine is located in the active site 
[25-27]. Chemical modification studies using haloacetates, such as iodoacetic acid, 
provided a second method to probe the importance of the histidine residue located in 
the active site. 
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Substrate recognition and binding plays a critical role in the effectiveness of an 
enzyme. In MDH, there are at least three arginine residues that participate in 
substrate recognition and binding. Arg81 is involved in binding the dicarboxylic acid 
substrate, and is located in the nucleotide binding region. Arg87 is located within a 
region of the enzyme that participates in conformational changes, which occur after 
the substrate has bound to the active site. The third arginine residue, Arg153, is 
located in the catalytic region of the enzyme. It participates in hydrogen bonding at 
the subunit interface and participates like Arg81, in substrate binding [ 10] . 
Certain 1,2-diketones, react in alkaline solution with the guanidino moieties of 
proteins. Of these 1,2-diketones, 1,2-cyclohexanedione, an arginine specific reagent, 
appears to be one of the most useful [24] and was used to verify the importance of 
arginine residues in eMDH. 
Over the years, much research has been done on LDH and on the eukaryotic 
cytosolic and mitochondrial MDH isozymes, yet eMDH has been relatively unstudied. 
The goal of this research is to propose a mechanism of action for eMDH, and also to 
compare eMDH with other MDHs in order to discover the similarities and differences 
in enzyme function. 
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Chapter II 
EXPERIMENTAL PROCEDURES 
1. Materials and Instruments 
a. Chemicals 
All reagents were obtained from Sigma Chemical Company unless otherwise 
specified. E. coli, strain HBlOl was purchased from American Type Culture 
Collection. Potassium phosphate dibasic was obtained from Aldrich Chemical 
Company Inc.. The Bradford dye reagent and Cibacron Blue (Affi-Gel Blue Gel, 
100-200 mesh) were obtained from Bio-Rad. DTT was purchased from Boehringer 
Mannheim Biochemicals. Diethylpyrocarbonate was obtained from Aldrich Chemical 
Company Inc. Iodoacetic acid was obtained from Eastman Organic Chemicals. 
b. Instruments 
Centrifugation was performed with a Sorvall SS-4 Manual Superspeed 
Centrifuge or a Beckman Microfuge 11 at 4°C. The sonification of E. coli cell paste 
was performed using a Bronw ill Scientific Biosonik III sonicator. A LKB Ultrospec 
4050 (non-thermostated) was used for routine protein and activity assays. The final 
enzyme assays, kinetic studies and chemical modification studies were performed on a 
Shimadzu UV-3100 Spectrophotometer with a thermostated microprocessor controlled 
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cell holder. 
2. Transformation of HB101 with pEM6 Plasmid by the Calcium Chloride Procedure 
A HB101 colony was picked from a refrigerated agar plate and was used to 
inoculate 5 mL of LB medium, which was incubated at 37°C for 12 h with shaking. 
One milliliter of the overnight culture was used to inoculate 100 mL of LB medium. 
The 100 mL culture was grown with vigorous shaking at 37°C for 2 to 4 h (density 
= 5 X 107 cells/mL). The culture was chilled on ice for 10 min and then was 
centrifuged at 4, 000 RPM for 5 min at 4 °C. The supernatant was decanted and 
discarded. The cells were resuspended in 5 mL of an ice-cold, sterile solution of 50 
mM CaC12 , 10 mM Tris, pH 8.0. The cell suspension was placed in an ice bath for 
15 min and then centrifuged at 4, 00 RPM for 5 min at 4 °C. 
The supernatant was discarded, and the cells were suspended in 1 mL of the 
ice-cold CaC12 solution. The cells were stored on ice for 24 h. The DNA (pEM6 
plasmid; 10 ng) in TE buffer was added to the cell, mixed gently, and placed on ice 
for 30 min. The cells were then heat-shocked at 42°C. One milliliter of LB medium 
was added to the cells, which were then allowed to incubate at 37°C for 1 h without 
shaking. The cells then were spread onto an LB agar plate containing 1 % ampicillin 
and incubated at 37°C for 14 h during which time the colonies appeared [28]. 
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3. Enzyme Assays 
The enzyme assays consisted of: 0.15 mM NADH, 0.10 mM OAA, 2 mM 
EDTA, and 50 mM HEPES buffer at pH 7.0. Routine activity assays were 
performed at room temperature while final assays, kinetic studies and chemical 
modification studies were performed at 25°C. The decrease in absorbance of NADH 
at 340 nm was measured. 
4. Protein Concentration Determination. 
Protein concentrations were determined by the method of Bradford (29], using 
bovine serum albumin as a standard. The protein concentration was also measured by 
absorbance at 205 nm in 5 mM K2P04, 50 mM Na2S04 buffer at pH 7.0. The 
extinction coefficient was determined by the formula: 
Ez051 mg/ml = 27.0 + 120 * (A280/A205) [30] 
5. Enzyme Purification. 
Malate dehydrogenase was isolated and purified from E. coli, strain HBlOl, 
containing the pEM6 plasmid which contained the MDH gene. HB101 cells 
containing the plasmid were plated out on a LB agar plate (10 g/L tryptone, 5 g/L 
yeast extract, 10 g/L NaCl and 15 g/L of agar) and incubated for 12 h at 37°C. 
Selected colonies were then replated onto LB agar plates that contained 1 3 ampicillin 
and were incubated at 37°C. Colonies from this plate were used to inoculate 4 test 
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-tubes of 5 ml of LB medium containing 1 3 ampicillin which were allowed to grow 
with shaking at 3 7°C. The contents of the test tubes were added to four one liter 
Fernbach flasks (1 test tube per flask) of LB medium. The flasks were incubated at 
37°C for 14 h with shaking at low speed on a orbital shaker located in a shaker room 
The suspension was centrifuged in a GSA rotor at 12,000 RPM at 4°C. The cell 
paste was collected, weighed, and then stored at -20°C. 
Approximately 0.1 g of the HB101/pEM6 cell paste was thawed and homogenized 
on ice with a magnetic stir bar in 10 mL of 50 mM KPi, pH 7.0. The homogenate 
was sonicated on ice at 55 3 of maximum power for 30 sec. The protein solution was 
allowed to cool for 1 min. This was repeated 10 times, the total sonication time was 
3 min. The resultant light grey protein slurry was then centrifuged at maximum 
speed in a SS-34 rotor for 30 min at 4°C. The supernatant, which contains the MDH, 
was decanted and the pellet was discarded. The supernatant was then assayed for 
activity and protein. 
Affi-Gel Blue Gel (15 mL) was washed with 500 mL of deionized water and was 
then equilibrated with 10 mM KPi buffer pH 7. 4. The supernatant was mixed with 
the equilibrated blue agarose, and was allowed to stand for 30 min with periodic 
stirring. This allowed the MDH to bind to the blue agarose. A column (30 mm x 
120 mm; 50 mL) was built with the MDH-bound blue agarose. The column was 
washed with pH 7. 5 KPi buffer to remove any unbound protein until the absorbance 
at 280 nm was less than 0.10. Approximately 15 3 of the total units were lost in the 
wash. The MDH was eluted from the column by using a 0 to 2 M NaCl gradient in 
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the pH 7.4 KPi buffer (total gradient volume was 100 mL). Fractions (3 mL total 
volume) were collected and assayed for MDH activity. Those fractions that exhibited 
activity were combined and assayed for activity and total protein. 
The protein concentration at this point was very low (0.4 mg/mL), therefore the 
eMDH was concentrated by using Centricon microconcentrators. The enzyme was 
loaded into the Centricons and was centrifuged at 3,500 RPM for 10 min at 4°C. The 
concentration process was continued until the protein concentration was greater than 1 
mg/mL. The eMDH was sterile filtered using a 0.2 µm pore size disposable sterile 
filter from Sigma Chemical Company. The final assay for activity and protein 
concentration was performed on a Shimadzu UV-3100 at 25°C. The protein 
concentration was determined by using the Bradford method and by absorbance at 205 
nm . The purity of the enzyme was checked by running a SDS polyacrylamide gel. 
6. Kinetic Isotope Studies. 
a. Synthesis and studies with malate-2-d 
Malate-2-d was synthesized by Dr. N. C. Furumo according to the article 
published by Viola, Cook, and Cleland [31]. Ethanol-d6 (7.4 mM), NAD+ (0.20 
mM), OAA (10 mM), 50 units of liver alcohol dehydrogenase, 250 units of aldehyde 
dehydrogenase, and 50 units of MDH were combined in 400 mL of PIPES at pH 7.0 
at 25°C. The amount of malate-2-d formed was monitored by adding 0.2 mL of 60% 
perchloric acid and 1. 8 mL of deionized water to 1 mL of the reaction mixture which 
quenched the reaction. The pH was adjusted to 8.0 with 1 M KOH and the volume 
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was brought to 10 mL. 
The malic enzyme assay for malate consisted of 3 mL of 100 mM TAPS at pH 
9.0, 2 units of chicken liver malic enzyme, lmM NAD+, 2 mM MgS04 , 1 mg/mL 
BSA, and 100 µM DTT. 
After the reaction was complete, the proteins and the PIPES were precipitated 
by adjusting the pH of the reaction mixture to 1 with perchloric acid. The mixture 
was then filtered and applied to a AG-l-X8, 200-400 mesh anion exchange column in 
the formate form. Malate-2-d was eluted using a 500 mL linear gradient from 0 to 4 
M of formic acid . 
The kinetic isotope effect was determined by assaying eMDH activity in the 
presence of either malate-2-d or malate. The assays contained 50 mM Taps buffer at 
pH 9.0, 100 mM KCl, 2 mM EDTA, 7.0 mM NAD+, 6.2 nM active sites, and 
malate-2-d or malate varying in concentration from 0.2 to 15 mM. The reaction was 
monitored by measuring the change in absorbance of NADH at 340 nm. 
b. Synthesis and studies with NADD. 
A-side NADD was prepared according to the published method by Viola, 
Cook and Cleland [31]. Ethanol-d6 (2. 8 mM), 5. 6 mM N AD+, 50 units horse liver 
alcohol dehydrogenase, and 100 units of yeast aldehyde dehydrogenase were mixed in 
10 mL of 10 mM Taps buffer, pH 9.0 at 27°C. The reaction was monitored by uv 
absorbance at 340 nm. The mixture was vortexed with several drops of CC14 to 
precipitate the proteins, The aqueous phase, which contained the NADD, was 
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removed. 
The kinetic isotope effect was determined by assaying eMDH activity in the 
presence of either NADH or NADD. The assays contained 50 mM Kpi buffer at pH 
7.2, 100 mM KCl, 2 mM EDTA, 0.15 mM NADH or NADD, 1.9 mM MDH, and 
OAA varying in concentration from 0.02 to 0.15 mM. The reaction was monitored 
by measuring the change in absorbance of NADH or NADD at 340 nm. 
7. pH Studies 
The buffers used for the pH studies are listed in Table 1: 
I Table 1. Buffers and respective pH I 
Buffer pH 
MES 5.5, 6.0, 6.5 
PIPES 7.0 
HEP ES 7.5, 8.0 
TAPS 8.5, 9.0 
CHES 9.5, 10.0, 10.5 
The assays contained 60 µM active sites. A 1000 dilution of 60 mM stock eMDH in 
100 mM KPI/100 mM KCl was needed to obtain measurable rates. The reaction 
mixtures were incubated for 3 min at 25°C. The reaction was initiated by the addition 
of 10 µL of diluted eMDH (62 nM active sites). Immediately after the addition of 
eMDH, the reaction mixtures were mixed well with a plunger and the initial rate 
(normally the first 5-20 sec) was recorded. The reaction mixtures consisted of 50 
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mM buffer, 100 mM KCl, 2.0 mM EDTA, and 6.2 nm active sites. The NAD+ was 
held constant at 7.0 mM, while the malate concentration was varied from 1 to 15 
mM. The rate of the reaction catalyzed by MDH was measured by monitoring the 
change in absorption of NADH at 340 nm at pH values listed in Table 1. 
8. Substrate Inhibition 
The substrate inhibition assays were composed of 50 mM PIPES, 2 mM 
EDTA, 100 mM KCl at pH 7.0 for OAA. The NADH concentration was held 
constant at 0.15 mM, while the OAA concentration was varied between 0.015 and 20 
mM. 
The malate substrate inhibition study was also performed in TAPS (50 mM), 
2 mM EDTA, 100 mM KCl, pH 9.0. NAD+ was fixed at 0.15 mM and malate was 
varied from 0.015 mM to 20 mM. 
The cofactor substrate inhibition studies were carried out in either 50 mM 
PIPES, 2 mM EDTA, 100 mM KCl at pH 7.0 for NADH or 50 mM TAPS, 2 mM 
EDTA, 100 mM KCl, pH 9.0 for NAD+. For the cofactor substrate inhibition 
experiments, OAA or malate was fixed at 0.10 mM and NADH or NAD+ was varied 
from 0.015 to 2 mM. 
The reaction mixtures were incubated for 3 min at 25°C. The reaction began with 
the addition of 10 µ,L of diluted MDH (62 nM active sites). Immediately after the 
addition of the MDH, the reaction mixtures were mixed well with a plunger and the 
initial rate was recorded. 
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9. Inhibition Studies with Substrate Analogs 
Four series of 5 assays were performed in which the citrate concentration was 
fixed from 0 to 4 mM (0, 1, 2, 4 mM). In each series, the enzymatic assays 
contained 50 mM TAPS buffer, 100 mM KCl, 7 mM NAD+ and 2.0 mM EDTA at 
pH 7. 0. Malate was varied from 0. 1 to 2. 0 mM, and there was 6. 2 nM active sites 
MDH. The reaction mixtures were incubated for 3 min at 25°C. Immediately after 
the addition of the MDH, the reaction mixtures were mixed well with a plunger and 
the initial rate was recorded at 25°C. The assays were monitored by measuring the 
change in absorbance of NADH at 340 nm. This experiment was repeated using 
malonate as the inhibitor instead of citrate. 
In order to determine if ketomalonate or malonate inhibited OAA, four series of 
5 assays were performed in which the ketomalonate or malonate concentration was 
varied from 0 to 4 mM (0, 1, 2, 4 mM). In each series, the enzymatic assays 
contained 50 mM PIPES buffer, 100 mM KCl, and 2.0 mM EDTA at pH 7.2. 
NADH was fixed at 0.15 mM, OAA was varied from 0.1 to 2.0 mM, and there was 
6.2 nM active sites MDH. The reaction mixtures were incubated for 3 min at 25°C. 
The reaction began with the addition of 10 µ.L of diluted eMDH. 
A third inhibitor study was performed with ATP (0, 1, 3, and 5 mM) being 
the inhibitor. The MAL was fixed at 1. 0 mM and N AD+ was varied from 0 .1 to 1. 0 
mM. All other aspects were the same as the above experiments. 
23 
10. Allosteric effects. 
The enzyme assays contained 6.2 nM active sites. The reaction mixtures were 
composed of 50 rnM TAPS buffer, 2.0 mM EDTA, and 100 mM KCl, pH 9.0 The 
NAD+ and NADH concentrations were held constant at 0.7 mM, while the MAL 
concentration was varied around 0. 9 mM (0 .1 - 20 mM). The reaction mixtures were 
incubated for 3 min at 25°C. The reaction began with the addition of 1 O µL of 
diluted MDH (62 nM active sites). Immediately after the addition of the MDH, the 
reaction mixtures were mixed well with a plunger and the initial rate was recorded. 
11. Chemical Modification. 
a. Treatment with diethylpyrocarbonate 
Diethylpyrocarbonate (97 % ) was diluted to 100 mM in anhydrous acetonitrile 
(HPLC grade). The concentration of the stock solution was determined quantitatively 
by absorption at 230 nM. A 10 µL aliquot of the 100 mM stock DEPC solution was 
added 990 µL of 10 mM imidazole at pH 7.5 and 25 °C. The increase in absorbance 
at 230 nm, which was due to N-carbethoxyimidazole (E = 3.0 mM-1 cm-1) formation 
was recorded. 
The stock eMDH solution used in the chemical modification studies had a 
specific activity of approximately 665 µ!mg. The enzyme concentration was 72 µM. 
The modification was carried out in 50 mM KPi, 100 mM KCl, at pH 6.5. 
Dicarbethoxyhistidyl derivatives, which cannot be reversibly modified, are formed in 
the presence of excess DEPC. A concentration of 0.75 mM DEPC yielded the best 
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modification and yet was still reversible. The degree of modification was determined 
by a decrease in MDH activity and by UV spectroscopy 
To quantify the number of modified histidine residues, a control was prepared by 
combining 50 µL of MDH (71 µM), 7.5 µL of anhydrous acetonitrile, and 943.5 µL 
of buffer (100 mM KPi, 100 mM KCl, pH 6.5) in a 1 mL quartz cuvette with a 1 cm 
path length. This was placed in the reference beam of the spectrophotometer. The 
modification reaction was composed of 50 µL of MDH (71 µM), 7.5 µL of DEPC 
(100 mM), 943.5 µL of buffer (100 mM KPi, 100 mM KCl, pH 6.5). The reaction 
mix was placed in a microfuge tube and incubated at 25°C for the duration of the 
experiment. At five minute intervals (including t = 0), 10 µL of the reaction mixture 
was removed and diluted 1/100 in an assay mix. A spectrum (320 -220 nm) was 
recorded every five minutes for 25 minutes and was used to quantify the number of 
histidine residues modified. 
In order to determine the loss of eMDH activity as a function of time, the 
following experiment was performed. Both the control mixture and the reaction 
mixture were prepared as above. The control sample again was placed in the 
reference beam of the spectrophotometer in the constant temperature cell holder. The 
deactivation was preformed at 25°C. At five minute intervals (including t = 0), 10 
µL were removed and diluted 1/100, from this dilution, 10 µL were removed (total 
dilution was 1/10,000 including the 1/100 dilution into the assay mix ) and then was 
assayed. The control was also assayed every five minutes. 
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The reactivation of MDH was done by again preparing the control and the 
reaction mixtures as described above. Both were incubated at 25°C for 25 minutes. 
Aliquots (310 µL) of both the sample and the control were removed and mixed with 
690 µL of 1.45 M NH20H, pH 7.0, to give a final concentration of hydroxylamine of 
1 M. An aliquot (10 µL) of both the control and the sample were removed and 
diluted 11100 in the assay mix and assayed at 340 nm every 15 min for 1 h. 
In order to determine the pH dependence of the rate of inactivation, the pH 
was varied from 6.0 to 8.0 in KPi buffer. A control was prepared by combining 20 
µL of eMDH (19 µM), 10 µL of anhydrous acetonitrile, and 970 µL of buffer (100 
mM KPi, 100 mM KCl, pH 6.0 - 8.0) in a 1 mL quartz cuvette with a 1 cm path 
length. A 10 µL aliquot was removed and assayed for activity. The activity assay 
conditions were as follows: 50 mM KPi at the various pH values specified above, 2 
mM EDTA, 100 mM KCl, 0.10 mM OAA, and 0.15 mM NADH The modification 
reaction was composed of 20 µL of eMDH (19 µM), lOµL of DEPC (100 mM), 970 
µL of buffer (100 mM KPi at the various pH values, 2 mM EDTA, and 100 mM 
KCl). 
b. Treatment with 1,2-cyclohexanedione 
A control for the 1,2-cyclohexanedione modification was prepared by 
combining 20 µL of MDH in 980 µL of 50 mM Na2B40il0 H20 at pH 8.5. The 
control was incubated at 25°C. An 10 µL aliquot was removed at 5 min intervals and 
assayed for activity at 340 nm for 1 hr. The assays were performed in 50 mM KPi, 
pH 7.2, 2 mM EDTA, 100 mM KCl, 0.10 mM OAA, 0.15 mM NADH, and 25°C. 
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1,2-cyclohexanedione (16 mM) was added to 8 µM MDH in 50 mM 
Na2B40 7 10 H20 at pH 8.5. The mixture was incubated at 25°C. A 10 µL aliquot 
was removed at 5 min intervals and assayed for activity at 340 nm for 1 hr [32]. 
c. Treatment with iodoacetic acid 
MDH was chemically modified with 10 mM iodoacetate at pH 5.5. A control 
was prepared by incubating 8 µM MDH in 50 mM MES buffer, pH 5.5. An 10 µL 
aliquot of the control mix was removed every 5 min and assayed for activity for 1 hr 
at 340 nm. The assay conditions were: 0.10 mM OAA, 0.15 mM NADH, 50 mM 
KPi at pH 7.2, 2 mM EDTA, 100 mM KCl and 25°C. 
The chemical modification mix contained 8 µM MDH, 10 mM iodoacetate, 50 
mM MES buffer, pH 5.5. An aliquot was removed and assayed for activity for every 
5 min for 1 hr. 
12. Data Analysis 
The kinetic data were analyzed by using the BASIC version of Cleland's 
FORTRAN programs [14]. Substrate inhibition data were fit to equation 3. 
(3) 
The pH profile kinetic parameters were determined at each pH by varying the 
concentration of malate, and fixing NAD+. The initial rate data was fit to equation 4. 
The V max and V /K values determined at each pH were fit to equation 5 and 6 
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respectively. 
v = VA/(K+A) (4) 
log Y = log(C/1 + ([H+]/KJ (5) 
log Y = log(C/(1 + Kb/[H])) (6) 
The isotope effect data were fit to equation 7 or 8, where I is the inhibitor. 
V/K = V*A/(K(l + I * VKI) + A) (7) 
v max = V*A/(K + A(l + I * VI)) (8) 
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Chapter III 
RESULTS 
1. Purification of Malate Dehydrogenase 
The protein concentration was determined by both the Bradford dye method and 
by absorbance at 205 nm [30] . The results of the purification process are shown in 
Table 2. 
Table 2. The results of the purification of eMDH. 
Total Total Total Units Specific 
protein (mg) volume (u) Activity 
(mL) (u/mg) 
4.2 a 8.0 23,721 706 
4.6 a 4.5 13,746 665 
5.2 b 
a Protein concentration determined by method of Bradford [29]. 
b Protein concentration determined by spectrophotometric method [30]. 
2. Kinetic Isotope Effect 
Kinetic isotope effect studies were performed in order to determine the rate 
limiting step of the oxidation of malate to OAA. Initial velocities were obtained with 
substrates protio-malate or malate-2d which were varied from 0.2 to 15 mM, while 
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NAD+ was held constant at 7 rnM. A double-reciprocal plot of l/V versus l/[protio-
malate or malate-2d] is presented in Figure 1. A KIE of 1.43 ( +0.14) was obtained 
on V/K by using the BASIC version of the FORTRAN programs of Cleland [14]. 
No isotope effect was observed on V. 
I Table 3a. Kinetic isotope effect data. I 
[Malate] Rate [Malate-2-d] Rate 
(mM) (AOD/min) (mM) (AOD/min) 
0.20 0.219 0.20 0.176 
0.50 0.354 0.50 0.289 
1.0 0.432 1.0 0.405 
2.0 0.453 2.0 0.446 
A kinetic isotope effect study was also performed using NADD. Initial 
velocities were obtained using NADH or NADD which were varied from 0.01 to 0.15 
mM while the OAA concentration was held constant at 0.10 mM. For V, a double-
reciprocal plot of l/V versus l/[NADH or NADD] is presented in Figure 2 and for 
V/K, a double reciprocal plot of 1/V versus 1/[NADH or NADD] is presented in 
Figure 3. A KIE of 1.22 (±0.19) was obtained on Vanda KIE of 1.08 (±0,.06) was 
obtained on V /K. 
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Fig. 1. The primary deuterium isotope effect on V/K was determined by plotting the 
inverse. rate data as a function of the inverse substrate concentration. The 
substrate was either protio-malate (•), or malate-2-d (O). 
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substrate was either NADD (•), or NADH (O). 
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substrate was either NADD (•), or NADH(o). 
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Table 3b. Kinetic isotope effect data. 
[NADH] Rate [NADD] Rate 
(mM) (i.lOD/min) (mM) (i.lOD/min) 
0.01 0.277 0.01 0.237 
0.03 0.646 0.03 0.831 
0.05 0.934 0.05 1.120 
0.10 1.712 0.10 1.507 
0.15 2.053 0.15 1.467 
3. pH Studies 
In order to determine the identity of the active site residue whose ionization is 
necessary for catalysis, pH variation studies were performed. The initial velocity was 
determined as a function of malate and NAD+ concentrations at various pH values. 
The kinetic parameters Km and V max and standard errors in Km were obtained from the 
data and are presented in Table 4. 
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Table 4. The kinetic parameters obtained from initial 
velocity studies at various pH values. Error in 
parenthesis. 
pH Km (malate) Keat 
10.0 2.81 (±6.4%) 1.37 (±2.0%) 
9.5 1. 97 ( ± 18. 5 % ) 1.48 ( ± 5. 2 % ) 
9.0 0.877 (±16.0%) 1.11 (±3.0%) 
8.5 0.488 ( ± 12.2 % ) 0.712 (±1.7%) 
8.0 0.418 (±11.2%) 0.461 (±3.8%) 
7.5 0.407 (±20.6%) 0.114 (±6.9%) 
7.0 0.708 (±11.9%) 0.0462 (±4.5 %) 
6.5 0.718 (±30.3%) 0.0232 (±.2%) 
6.0 1.25 (±23.4%) 0.0234 ( ± 10. 7 % ) 
5.5 2.27 (±34.9%) 0. 0207 ( ± 18. 1 % ) 
The data were fit to a pH-profile kinetics program [14], from which a pKa 
value of 7.80 (±0.08) and 7.91 (±0.12) for V/K and V max respectively. The V/Kmai 
pH rate profile is presented in Figure 4 and the V max profile is presented in Figure 5. 
The break observed corresponds to a pK value of approximately 8.0. The data for 
the rate versus [malate] at various pH values is located in Table 5 and the pH profile 
data is located in Table 6. 
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Fig. 4. The data were plotted as a function of pH to determine the effect of pH on 
log(V /Kma1). The line represents the best fit of the data to equation 5, from 
which a pKa of 7. 8 was determined. 
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from which a pl<a of 7 .91 (±0.12) was determined. 
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Table 5. Rate versus [malate] at various pH values. 
pH [malate] (mM) Rate (~OD/min) 
5.5 0.10 0.0009 
0.25 0.003 
1.0 0.006 
3.0 0.012 
6.0 0.25 0.004 
0.50 0.007 
1.0 0.010 
3.0 0.017 
6.5 0.25 0.008 
0.50 0.009 
1.0 0.012 
3.0 0.019 
7.0 0.25 0.013 
0.50 0.019 
1.0 0.026 
3.0 0.038 
7.5 0.10 0.029 
0.25 0.044 
0.50 0.066 
1.0 0.076 
3.0 0.104 
8.0 0.10 0.092 
0.25 0.176 
0.50 0.257 
1.0 0.308 
3.0 0.413 
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I Table 5. Continued. I 
pH [malate] (mM) Rate (~OD/min) 
8.5 1.0 0.485 
3.0 0.609 
5.0 0.629 
10.0 0.695 
15.0 0.693 
9.0 1.0 0.585 
3.0 0.845 
5.0 1.01 
10.0 1.01 
15.0 1.03 
9.5 1.0 0.452 
3.0 0.904 
5.0 1.11 
10.0 1.28 
15.0 1.24 
10.0 1.0 0.366 
3.0 0:698 
-
5.0 0.893 
10.0 1.05 
15.0 0.17 
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I Table 6. pH profile data. I 
pH log (V/K) 
10.0 -0.3312 
9.5 -0.1242 
9.0 0.1023 
8.5 0.1640 
8.0 0.0425 
7.5 -0.5527 
7.0 -1.185 
6.5 -1.491 
6.0 -1. 728 
5.5 -2.040 
4. Substrate Inhibition: 
At high concentrations, both NADH and OAA display substrate inhibition. An 
apparent Ki value of -4.4 X 10-4 for NADH and 8.1 X 10-1 for OAA were obtained. 
Since the substrate inhibition patterns for NADH and OAA do not intersect the 
vertical axis, the inhibition by both of these substrates is complete at saturating levels 
(Figures 6 and 7). The products of the forward reaction, malate and NAD+, 
displayed no substrate inhibition. 
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Fig. 6. Substrate inhibition by NADH was determined by plotting the inverse of the 
rate data as a function of the inverse of NADH concentration. This plot 
shows that substrate inhibition occurs at high concentrations of OAA (above 
10 mM). 
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Fig. 7. Substrate inhibition by OAA was determined by plotting the inverse of the 
rate data as a function of the inverse of OAA concentration. This plot 
shows that substrate inhibition occurs at high concentrations of NADH 
(above 10 mM). 
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I Table 7. NADH substrate inhibition data. I 
[NADH] (mM) Rate (.:lOD/min) 
0.015 0.043 
0.05 0.068 
0.10 0.101 
0.25 0.203 
0.50 0.302 
0.70 0.161 
0.80 i 0.136 
0.90 0.034 
1.0 0.022 
1.5 0.012 
2.0 0.006 
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I Table 8. OAA substrate inhibition data. I 
[OAA] (mM) Rate (~OD/min) 
0.015 0.109 
0.05 0.518 
0.10 2.07 
0.25 3.00 
0.50 3.22 
0.60 2.60 
0.70 2.69 
0.80 2.76 
0.90 2.64 
1.00 2.36 
1.50 2.27 
2.00 1.62 
5.00 0.546 
10.0 0.627 
15.0 0.714 
20.0 0.544 
5. Inhibition studies with Substrate Analogs 
None of the substrate analogs (ATP, citrate, ketomalonate, or malonate) were 
bound tightly by eMDH as indicated by the relatively high Ki's. The substrate analog 
inhibition data is presented in Table 9, and the calculated inhibition constants are 
located in Table 10. 
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Table 9. Substrate analog inhibition by various concentrations 
of substrate analogs. 
[malate] (mM) [citrate] (mM) Rate (AOD/min) 
0.10 0 0.1626 
0.50 0 0.4630 
0.75 0 0.6229 
0.90 0 0.6425 
1.30 0 0.7952 
1.70 0 0.8136 
2.00 0 0.9098 
0.10 0.1 0.1176 
0.50 0.1 0.4423 
0.90 0.1 0.5921 
1.5 0.1 0.6998 
2.00 0.1 0.7311 
0.10 0.5 0.1535 
0.50 0.5 0.4721 
1.50 0.5 0.6534 
2.00 0.5 0.6765 
0.10 1.0 0.0614 
0.50 1.0 0.2230 
0.90 1.0 0.2773 
1.50 1.0 0.3522 
2.00 1.0 0.3707 
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I Table 9. Continued. I 
[malate] (mM) [malonate] (mM) Rate (~OD/min) 
0.10 0 0.1626 
0.50 0 0.4630 
0.75 0 0.6229 
0.90 0 0.6425 
1.30 0 0.7952 
1.70 0 0.8136 
2.00 0 0.9098 
0.10 0.10 0.1482 
0.50 0.10 0.4699 
0.90 0.10 0.6616 
1.50 0.10 0.6612 
2.00 0.10 0.7401 
0.10 3.0 0.1322 
0.50 3.0 0.3914 
0.90 3.0 0.5502 
1.50 3.0 0.6452 
2.00 3.0 0.6695 
0.10 7.5 0.0443 
0.50 7.5 0.1571 
0.90 7.5 0.1566 
1.50 7.5 0.2622 
2.00 7.5 0.2640 
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I Table 9. Continued. I 
[OAA] (mM) malonate (mM) Rate (.!iOD/min) 
0.010 0 0.0686 
0.033 0 0.1671 
0.055 0 0.2564 
0.078 0 0.2681 
0.10 0 0.2475 
0.010 1.0 0.050 
0.055 1.0 0.1869 
0.078 1.0 0.1864 
0.10 1.0 0.2057 
0.010 8.0 0".0800 
0.055 8.0 0.1644 
0.078 8.0 0.1782 
0.10 8.0 0.1670 
0.010 15.0 0.0489 
0.033 15.0 0.0790 
0.055 15.0 0.0900 
0.078 15.0 0.1043 
0.10 15.0 0.1282 
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I Table 9. Continued. I 
[OAA] (mM) [ketomalonate] Rate (~OD/min) 
(mM) 
0.010 0 0.0686 
0.033 0 0.1671 
0.055 0 0.2564 
0.078 0 0.2681 
0.10 0 0.2475 
0.010 2.0 0.1227 
0.033 2.0 0.1852 
0.055 2.0 0.2025 
0.078 2.0 0.2058 
0.10 2.0 0.2207 
0.010 5.0 0.0926 
0.033 5.0 0.1495 
0.055 5.0 0.1601 
0.078 5.0 0.1681 
0.10 5.0 0.1655 
0.010 8.0 0.0747 
0.033 8.0 0.1213 
0.055 8.0 0.1396 
0.078 8.0 0.1469 
0.10 8.0 0.1705 
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I Table 9. Continued. I 
[NAD+] (mM) [ATP] (mM) Rate (.:lOD/min) 
0.10 0 0.1911 
0.30 0 0.4943 
0.50 0 0.7083 
0.70 0 0.8667 
1.10 0 1.0150 
0.10 1.0 0.1628 
0.30 1.0 0.3868 
0.50 1.0 0.5649 
0.70 1.0 0.6845 
0.90 1.0 0.7579 
1.10 1.0 0.8671 
0.10 3.0 0.1243 
0.30 3.0 0.2923 
0.50 3.0 0.4463 
0.70 3.0 0.5157 
0.90 3.0 0.6134 
1.10 3.0 0.6602 
0.10 5.0 0.0894 
0.30 5.0 0.2199 
0.50 5.0 0.3285 
0.70 5.0 0.4305 
1.10 5.0 0.4961 
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Table 10. The kinetic parameters obtained from the substrate analog inhibition 
studies. 
Substrate/Inhibitor K15 (competitive) Kn Kn 
(uncompetitive) (noncompetitive) 
malate/ citrate 3.2 x 10-1 5.89 x 10-1 NIA 
malate/malonate 1.67 3.72 NIA 
OAA/malonate 4.37 9.82 1.13 x 10+1 
OAA/ketomalonate 3.22 8.85 7.34 
NAD+/ATP 2.20 1.97 6.92 
6. Allosteric Effects: 
To determine if MDH exhibited allosteric behavior, an experiment was 
performed, in which malate was varied between 0.1 and 13.0 mM, NAD+ was fixed 
at 0.10 mM, NADH was fixed at 0.065 mM, and 100 mM KCl. The allosteric effect 
plot is presented in Figure 8. 
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Table 11. Allosteric effect data. Conditions: 50mM Taps pH 
9.0, 100 mM KCl, Malate varied, NAD+ fixed at 7 mM, 
and NADH fixed at 0.065 mM, and 25°C. 
[malate] (mM) Control Rate [NADH] (mM) Rate (.6.0Dlmin) 
(.6.0Dlmin) 
0.10 0.032 0.065 0.002 
0.50 0.071 0.065 0.004 
1.0 0.123 0.065 0.0089 
2.0 0.176 0.065 0.044 
3.0 NIA 0.065 0.053 
5 ') 0.236 0.065 0.078 
7.0 NIA 0.065 0.094 
10.0 0.291 0.065 NIA 
13.0 NIA 0.065 0.114 
7. Chemical Modification: 
For the chemical modification with DEPC, there were 14.85 µM histidines in 
the assay mixrilre. Table 12 shows the concentration of histidine residues modified 
with 0.75 mM DEPC over a 25 min time interval. 
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Fig. 8. An allosteric effect was detennined by plotting the rate as function of malate 
concentration with or without NADH. Control (O), 0.065 mM NADH (•). 
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Table 12. Results of Chemical Modification with 0. 75 mM 
DEPC. 
Time (min) Absorbance = [Histidine] (µM) 
340 nm 
0 0.03 9 
5 0.039 12 
10 0.0455 14 
15 0.0475 15 
20 0.0485 15.2 
25 0.050 15.6 
From Table 12, we see that after 25 min all of the histidine residues have been 
modified. When treated with 0.75 mM DEPC, eMDH shows a loss of catalytic 
activity (Figure 9). 
I Table 13. Inactivation of eMDH with 0. 75 mM DEPC I 
Time (min) Control Rate Modified Rate 
(.:lOD/min) (.:lOD/min) 
0 0.2788 0.2505 
5 0.2781 0.1464 
10 0.2759 0.1227 
15 0.2737 0.1149 
20 0.2689 0.1021 
25 0.2691 0.0997 
The loss of catalytic activity (Figure 10) corresponds to the concentration of modified 
histidine residues. 
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Fig. 9. The inactivation of eMDH with 0.75 mM DEPC. A loss of catalytic activity 
is observed in the presence of 0.75 mM DEPC. eMDH (7.4 µM Active sites) 
was incubated with 0.75 mM DEPC at 25°C and assayed for activity every 5 
min. 
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Fig. 10. Loss of eMDH activity is dependent on the concentration of modified 
histidine residues. 
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The reactivation study shows the reaction is reversible and the catalytic activity can be 
returned. Figure 11, shows 743 of the catalytic activity of MDH was returned by 
removal of the histidine modifications with 1 M hydroxy lamine. 
Table 14. Reactivation of DEPC modified eMDH with 1 M 
hydroxylamine. 
Time (min) Control Rate Reactivation Rate 
(AOD/min) (AOD/min) 
0 0.2701 0.1033 
15 0.2687 0.1141 
30 0.2659 0.1867 
45 0.2674 0.2067 
60 0.2639 0.1991 
Activity assays \\-.;;re also performed in order to determine the effects of 1,2-
cyclohexanedione on the catalytic activity of eMDH. The effects of the treatment of 
MDH with 16 mM 1,2cyclohexanedione, which is an 81 % decrease in catalytic 
activity, is presented in Figure 12. 
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Fig. 11. The reactivation of DEPC modified eMDH with 1 M hydroxylamine. 
DEPC chemically modified eMDH shows an increase in enzyme activity 
when treated with 1 M hydroxylamine. eMDH (7.4 µM active sites) was 
incubated with 1 M hydroxylamine, pH 7 .0 at 25°C and was assayed for 
activity every 15 min. 
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Fig. 12. The inactivation of eMDH with 16 mM 1,2-cyclohexanedione. A loss of 
catalytic activity is observed in the presence of 16 mM 1,2-
cyclohexanedione. eMDH (7.4 µ.M Active sites) was incubated with 16 
mM 1,2-cyclohexanedione at 25°C and assayed for activity every 5 min. 
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Table 15. Inactivation of eMDH with 16 mM 1,2-cyclohexanedione. 
Time (min) Control Rate Modified Rate 
(AOD/min) (AOD/min) 
0 0.3793 0.3743 
5 0.3753 0.3560 
10 0.3714 0.2588 
15 0.3454 NIA 
20 0.3324 0.1877 
25 0.3219 0.1662 
30 0.3604 0.1115 
35 0.3266 0.0855 
40 0.3497 0.0874 
45 0.3491 0.0555 
50 0.3760 0.0562 
55 0.3130 0.0591 
The catalytic activity was also determined in order to determine the effects of 
iodoacetic acid on MDH. The enzyme showed a 52 % decrease in activity upon 
treatment with 10 mM iodoacetic acid (Figure 13). In addition, Figure 14 shows that 
the loss of enzyme activity by modification of iodoacetic acid can be prevented if the 
modification is carried out in the presence of 7 mM NAD+. 
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Fig. 13. The inactivation of eMDH with 10 mM iodoacetic acid. A loss of catalytic 
activity is observed in the presence of 10 mM iodoacetic acid. eMDH (7.4 
µM Active sites) was incubated with 10 mM iodoacetic acid at 25°C and 
assayed for activity every 5 min. 
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Fig. 14. Protection of eMDH against 10 mM iodoacetic acid with 7 mM NAD+. 
eMDH when treated with 10 mM iodoacetic acid, in the presence of 7 mM 
NAD+ at 25°C, shows virtually no loss of catalytic activity. 
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Table 16. Inactivation of eMDH with 10 mM Iodoacetic acid and 
protection with 7 mM NAD+. 
Time (min) Control Rate Modified Rate Protected Rate 
(~OD/min) (~OD/min) (~OD/min) 
0 0.4864 0.4115 0.4707 
5 0.4169 0.2475 NIA 
10 0.4134 0.2640 0.4024 
15 0.4184 NIA NIA 
20 0.3960 0.2349 0.3850 
25 0.4170 0.2178 0.3980 
Chemical modification with DEPC was performed at various pH values to 
further identify the pK of the histidine residue involved in catalysis. The initial rates 
were plotted vs. time for pH 8.0-6.5. A pK of approximately 6.8 was determined 
from the plot of the rate of inactivation vs. pH (Figure 15). 
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Fig. 15. Rate of inactivation of eMDH plotted as a function of pH. From the plot, a 
pK of approximately 7 .0 was determined. 
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Table 17. Inactivation of eMDH with 1.0 rnM DEPC at various pH 
values. 
pH Time (min) Control Rate Modified Rate 
(averaged) (.lODlmin) 
(.lODlmin) 
6.0 0 NIA NIA 
5 0.37 0.32 
10 NIA 0.30 
15 0.37 0.26 
20 NIA 0.24 
25 0.36 0.23 
35 NIA NIA 
45 0.37 0.20 
6.5 0 NIA NIA 
5 0.37 0.34 
10 NIA 0.27 
15 0.37 0.20 
20 NIA 0.19 
25 0.36 0.20 
35 NIA 0.19 
45 0.37 0.17 
7.0 0 NIA NIA 
5 0.37 0.27 
10 NIA 0.23 
15 0.37 0.20 
20 NIA 0.17 
25 0.36 0.13 
35 NIA 0.13 
45 0.37 0.12 
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I Table 17. Continued. I 
pH Time (min) Control Rate Modified Rate 
(averaged) (.:iODlmin) 
(.:iODlmin) 
7.5 0 NIA NIA 
5 0.37 0.27 
10 NIA 0.17 
15 0.37 0.11 
20 NIA 0.082 
25 0.36 0.064 
35 NIA 0.061 
45 0.037 0.060 
8.0 0 NIA 0.16 
10 NIA 0.061 
15 0.037 0.045 
20 NIA 0.042 
25 0.36 0.022 
35 NIA 0.026 
45 0.37 0.018 
65 
Table 18. Rate of inactivation of eMDH in the presence of 1.0 
mM DEPC at various pH values. 
pH Control Slope DEPC Modified Slope 
8.0 6.95 x 10-4 -2.02 x 10-2 
7.5 9.40 x 10-5 -1.55 x 10-2 
7.0 -4.85 x 10-4 -8.96 x 10-3 
6.5 -3.98 x 10-4 -6.15 x 10-3 
6.0 1.89 x 10-3 -3.89 x 10-3 
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Chapter IV 
Discussion 
The results of this body of research in combination with the work of Fang 
Jenny Zhao [34] indicate that eMDH has a histidine residue that is essential for 
catalytic activity. This residue most probably functions as a general acid/base in the 
catalytic mechanism (Scheme Ill). The results of these studies are similar to those 
conducted by Bernstein and Everse, on mMDH from chicken heart, which indicated 
that an ionizing group with a pK of 7 .5 is involved in the binding of malate and the 
substrate analogue hydroxymalate [33]. 
There are many reasons why rates may vary with pH: (1) the substrate or a 
catalytic group on the enzyme might have to be in a specific state of protonation for 
the reaction to occur, or (2) protonation of groups remote from the active site may 
cause a conformational change [13]. In the case of eMDH, the catalytic group(s) on 
the enzyme must be in a given state of protonation for the reaction to occur. The 
residue must be protonated for the forward reaction and unprotonated for the reverse 
reaction, which is characteristic for groups involved in acid/base catalysis. 
1. Identification of an Active Site Histidine Residue 
In order to determine the pK of the active site amino acid residue involved in 
catalysis, pH studies were performed. Only one ionizing group with a pKa 
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Scheme III. A proposed role for the active site histidine. 
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between 7.8 and 8.7 was determined regardless of the direction of which the reaction 
was carried out. It is our belief that these two pKa values represent the ionization of 
a histidine residue located in the active site of the eMDH. Further support comes 
from a pK of 8.7 (+0.1), which was calculated from log V/KNADH vs.pH profile [34] 
and from a pKa of approximately 7 from a plot of rate of inactivation vs. pH (Fig 15). 
A role proposed for this active site histidine is presented in Scheme III. The 
microenvironment within the active site perturbs the pKa of histidine from the normal 
pKa of 6.0 to an elevated value between 7.8 and 8.5. An explanation for the increase 
in pK can be found in the crystal structure [9, 10]. Asp150 forms an ion pair with 
the histidine residue thus elevating the pKa of the catalytic essential Hisl 77 (Scheme 
Ill). 
The results of the DEP chemical modification studies further substantiate that a 
histidine residue is located in the active site. The loss of enzyme activity can be 
directly correlated with the concentration of modified histidine residues, as presented 
in Fig. 10. Treatment of modified eMDH with 1 M hydroxylamine restored 743 of 
the enzyme's activity, again suggesting a histidine residue is involved in catalysis. 
Furthermore, the rates of inactivation by DEPC were decreased by a factor of 8 and 4 
fold when NADH or OAA were present, indicating that the histidine residue is 
located in the active site [34]. 
To further support the conclusion that a histidine was involved in catalysis, 
eMDH was modified with iodoacetic acid which is another histidine-modifying 
reagent. When eMDH was treated with iodoacetic acid, a loss of activity was 
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observed. 
There are many research reports which propose the participation of a histidine 
residue in malate dehydrogenases, [2, 25-27, and 35]. The crystal structure of eMDH 
has been determined in the presence of citrate, and NAD+, and it clearly shows 
His 177 at the active site within hydrogen bond distance of the bound citrate and 
NAD+ [9, 10]. 
The log V profile of malate indicates malate binding requires that the enzyme 
must be in the correct protonated form (Fig. 5). This is somewhat different from 
mMDH from chicken heart in which both malate and OAA bind to the unprotonated 
form of the enzyme [33]. 
2. Kinetic Isotope Effects 
A critical process in enzyme catalysis is the abstraction of hydrogen from 
carbon, and primary hydrogen isotope effects have been useful in the investigation of 
enzyme catalyzed proton abstraction reactions. Hydrogen abstraction reactions usually 
have kinetic isotope effects that range from kH/k0 = 2-10 [36]. Our primary 
deuterium isotope effect studies indicate that proton abstraction is partially rate 
determining at non-saturating substrate levels at pH 9. 0. A primary isotope 
experiment was performed with NADD to determine if proton abstraction is partially 
rate limiting in the forward direction. Ordered mechanisms, such as that observed by 
eMDH where NADH (NAD+) bind first, followed by OAA (MAL) exhibit no isotope 
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effect on V because the release of the second product (NADH) limits V. The kinetic 
isotope effect value of 1.44 for V /K is in good agreement with a value of 1. 5 
obtained for LDH using 2-2H-lactate[37]. This enzyme shows a small isotope effect 
on the chemical conversion step because the cofactor is bound very tightly to the 
enzyme. Many dehydrogenases are characterized by small isotope effects on V /K and 
no isotope effect on V. Northrop has suggested that there should be no KIE on V 
when the release of the cofactor is the slowest step in catalysis [38]. Small isotope 
effects on V and V /KoAA were observed when NADD was present at fixed 
concentrations (0 .13 mM) and variable OAA at pH 7. 2. This coincides with an 
ordered mechanism in which the cofactor binds first and release of cofactor is rate 
determining. [38, 39]. No KIE was observed on V /KNADD(Hl• since binding of labeled 
substrate is not likely to be an isotopically sensitive step. This is again consistent 
with an ordered mechanism. 
3. Kinetic Mechanism 
Malate dehydrogenases are proposed to follow an ordered sequential 
mechanism, in which the cofactor is the first to bind and the last to be released 
(Scheme II), and the release of the cofactor is rate determining [2, 4, 25, 27,and 35]. 
Work by James Rardin has shown that eMDH operates by a Bi Bi sequential ordered 
mechanism. 
The results of the pH studies, chemical modification studies with both DEPC and 
iodoacetic acid, and the kinetic isotope effect studies indicate that eMDH is quite 
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similar to both cMDH and mMDH as well as LDH. The proposed mechanism for 
eMDH involves a single ionizing group with a pKa in the range of 7.8 to 8.5, which 
is most likely a histidine (Hisl 77). This histidine acts as a general acid in the 
n'duction of OAA and a general base in the oxidation of malate. The chemical 
conversion step is partially rate determining under non-saturating conditions, while 
under saturating conditions the release of the cofactor is most likely rate determining. 
4. Substrate Inhibition 
Several other kinetic studies and another chemical modification experiment 
were performed in order to further characterize the enzyme. It was found that OAA 
acts as a substrate inhibitor, most probably because: 1.) High concentrations of 
substrate alter the order of addition of the reactants or the reaction pathway. 2.) The 
substrate may bind at an allosteric site and result in either partial or total substrate 
inhibition [ 14] . 
From the l/Rate vs. 1/[S] plot, it can be seen that NADH or OAA displays the 
characteristic upward curve at low 1/[S] values. However, the Ki is negative for 
NADH; a meaningless results. The difficulty of measuring the rate at moderate to 
high NADH concentrations stems from the extremely high absorbances at moderately 
high NADH concentrations. Thus, the data from these studies are suspect and 
requires more investigation. 
5. Allosteric Effects 
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As mentioned above, the substrate may possibly bind at an allosteric site which 
results in substrate inhibition. Sandwal, determined that eMDH was allosterically 
regulated in the presence of low concentrations of NADH [7]. In this research, an 
allosteric effect has been observed in the reverse direction in the presence of a low 
concentration (0.065 mM) of NADH and 100 mM KCl (Fig. 6). This suggests that 
NADH is binding to a site other than the active site, thereby causing a conformational 
change in the enzyme. An allosteric effect in the forward direction has not been 
observed due to the fast initial velocities with OAA, which could possibly yield data 
that exhibits a sigmoidal curve, but in fact was not allosteric in nature [1, 7]. 
6. Inhibition Studies with Substrate Analogs 
By using substrate analogs, we are able to probe the active site of eMDH. At 
this point, we are unsure of the mode of inhibition of many of the inhibitors used. 
From the inhibitor studies however, we find that MDH is very specific for its 
substrates due to the relatively high Ki values (Table 10). 
7. Identification of Active Site Arginine Residues 
Arginine residues have been implicated in the binding of OAA and malate in 
eMDH. To determine their importance, a chemical modification experiment was 
carried out using 1,2-cyclohexanedione, an arginine specific reagent. When eMDH is 
treated with 1,2- cyclohexanedione, a loss of enzymatic activity is observed. This 
indicates that arginine residues are important to the function of eMDH, but does not 
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give any information regarding the location of the residues. 
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APPENDIX I 
KINETIC FIT PARAMETERS 
CONST. 
K= 
V= 
VALUE 
2.7364E-Ol 
5.3556E-Ol 
S.E. 
3.3170E-02 
l.6607E-02 
Weight 
9.0887E+02 
3.6259E+03 
V/K ISOTOPE EFFECT = 1.436 S.E. = l.4398E-Ol 
SIGMA = l.500109E-02 
VARIANCE= 2.250328E-04 
V/K ISOTOPE EFFECT FIT-MALATE 
CONST. 
K= 
V= 
VALUE 
l.0620E-Ol 
3.4439E+OO 
V ISOTOPE EFFECT= 1.385 
SIGMA= .1398673 
VARIANCE = l.956286E-02 
S.E. 
3.2778E-02 
5.8636E-Ol 
S.E. = 
Vmax ISOTOPE EFFECT FIT-NADH 
CONST. 
K= 
V= 
VALUE 
8.5195E-02 
2.9639E+OO 
S.E. 
3.2769E-02 
5.4109E-Ol 
Weight 
9.3077E+02 
2.9085E+OO 
l.9587E-Ol 
Weight 
9.3125E+02 
3.4155E+OO 
V/K ISOTOPE EFFECT= 1.209 
SIGMA = .1766875 
VARIANCE = 3.121847E-02 
S.E. = 2.2530E-Ol 
V/K ISOTOPE EFFECT FIT-NADH 
78 
CONST. 
c 
l/C 
pKa 
VALUE 
9.91610-01 
1.00850+00 
7.79780+00 
SIGMA = 5.53300-01 
VARIANCE= 3.06140-01 
S.E. 
2.79060-01 
2.83800-01 
1.87880-01 
The variable V/K increases as the pH increases 
CONST. 
V= 
K= 
K/V= 
l/V= 
KI= 
l/KI= 
SIGMA= 
VARIANCE= 
VALUE 
5.87000+00 
2.21250-01 
3.76920-02 
1.70360-01 
8.07730-01 
l.2380E+OO 
S.E. 
2.29110+00 
1.51000-01 
l.27140-02 
6.64900-02 
5.42190-01 
8.31040-01 
4.1825030-01 
1.7493330-01 
SUBSTRATE INHIBITION-QA.A 
CONST. 
V= 
K= 
K/V= 
l/V= 
KI= 
l/KI= 
SIGMA= 
VARIANCE= 
VALUE 
2.40100+05 
-3.11950+02 
-1.29920-03 
4.16490-06 
-4.35700-04 
-2.2952E+03 
S.E. 
2.05570+08 
1.33410+05 
5.56770-01 
3.56590-03 
1.86400-01 
9.81920+05 
1.0802860+02 
1.1670180+04 
SUBSTRATE INHIBITION-NADH 
79 
Weight 
l.9051E-Ol 
4.3855E+Ol 
6.1861E+03 
2.2620E+02 
3.4017E+OO 
1.4480E+OO 
Weight 
2.3663E-17 
5.6189E-ll 
3.2259E+OO 
7.8644E+04 
2.8781E+Ol 
l.0372E-12 
CONST. 
V= 
K= 
K/V= 
l/V= 
KI= 
l/KI= 
SIGMA= 
VARIANCE= 
VALUE 
5.60650-01 
2.72540+00 
4.86120+00 
1.78360+00 
6.59480+01 
l.5163E-02 
S.E. 
4.83720-02 
3.51210-01 
2.44960-01 
1.53890-01 
2.75030+01 
6.32370-03 
9.8025320-03 
9.6089640-05 
SUBSTRATE INHIBITION-MALATE 
CONST. 
V= 
K= 
K/V= 
l/V= 
KI= 
l/KI= 
SIGMA= 
VARIANCE= 
VALUE 
2.68880-02 
6.68150-02 
2.48490+00 
3.71920+01 
-2.00810+00 
-4.9798E-Ol 
S.E. 
5.36800-03 
9.78910-02 
3.27700+00 
7.42510+00 
8.77200-02 
2.17530-02 
1.3657440-02 
1.8652560-04 
SUBSTRATE INHIBITION-NAO+ 
CONST. 
K= 
V= 
KIS= 
l/KIS= 
SIGMA= 
VARIANCE= 
VALUE 
5.99280-01 
1.12940+00 
3.20700-01 
3.11820+00 
S.E. 
l.84140-01 
1.19870-01 
8.94960-02 
2.79070-01 
7.5097340-02 
5.6396110-03 
Weight 
4.2738E+02 
8.1070E+OO 
l.6665E+Ol 
4.2226E+Ol 
l.3221E-03 
2.5007E+04 
Weight 
3.4704E+04 
1. 0436E+02 
9.3119E-02 
l.8138E-02 
l.2996E+02 
2.1133E+03 
Weight 
2.9492E+Ol 
6.959SE+Ol 
l.248SE+02 
l.2841E+Ol 
COMPETITIVE INHIBITION-MALATE VS CITRATE 
80 
CONST. 
K= 
V= 
KIS= 
1/KIS= 
SIGMA= 
VARIANCE= 
VALUE 
5.10350-01 
1.03950+00 
1.66900+00 
5.99170-01 
S.E. 
1.6798D-01 
1.1019D-01 
5.09280-01 
3.05150-01 
8.4228720-02 
7.0944760-03 
Weight 
3.5437E+Ol 
8.2358E+Ol 
3.8555E+OO 
1.0739E+Ol 
COMPETITIVE INHIBITION-1'1.ALATE VS MALONATE 
CONST. 
K= 
V= 
KIS= 
1/KIS= 
SIGMA= 
VARIANCE= 
VALUE 
2.63730-02 
3.11560-01 
4.37890+00 
2.28370-01 
S.E. 
1.13060-02 
4.10740-02 
1.66470+00 
3.80160-01 
2.7280300-02 
7.4421470-04 
Weight 
7.8226E+03 
5.9274E+02 
3.6085E-01 
6.9194E+OO 
COMPETITIVE INHIBITION-OAA VS MALONATE 
CONST. 
K= 
V= 
KIS= 
1/KIS= 
SIGl'1A= 
VARIANCE= 
VALUE 
1.37520-02 
2.73870-01 
3.21530+00 
3.11010-01 
S.E. 
5.62800-03 
2.44490-02 
1.48540+00 
4.61970-01 
2.6970330-02 
7.2739870-04 
Weight 
3.1572E+04 
l.6729E+03 
4.5324E-01 
4.6856E+oo 
COMPETITIVE INHIBITION-OAA VS KETOMALONATE 
81 
CONST. 
K= 
V= 
KIS= 
l/KIS= 
SIGMA= 
VARIANCE= 
VALUE 
5.98230-01 
1.54870+00 
2.19910+00 
4.54740-01 
S.E. 
6.16430-02 
7.44490-02 
1.71750-01 
7.81020-02 
2.4221370-02 
5.8667470-04 
COMPETITIVE INHIBITION-NAD+ VS ATP 
CONST. 
K= 
V= 
KII= 
l/KII= 
SIGMA= 
VARIANCE= 
VALUE 
8.68510-01 
1.30510+00 
5.89380-01 
1.69670+00 
S.E. 
1.99560-01 
1.30220-01 
1.09670-01 
1.86080-01 
6.2098700-02 
3.8562480-03 
Weight 
2.6317E+02 
l.8042E+02 
3.3899E+Ol 
l.6394E+02 
Weight 
2.5110E+Ol 
5.8969E+Ol 
8.3142E+Ol 
O.OOOOE+OO 
UNCOMPETITIVE INHIBITION-MALATE VS CITRATE 
CONST. 
K= 
V= 
KII= 
l/KII= 
SIGMA= 
VARIANCE= 
VALUE 
6.76230-01 
1.14240+00 
3.72440+00 
2.68500-01 
S.E. 
2.04230-01 
1.31290-01 
8.42830-01 
2.26300-01 
8.2885150-02 
6.8699470-03 
Weight 
2.3975E+Ol 
5.8014E+Ol 
l.4077E+OO 
O.OOOOE+OO 
UNCOMPETITIVE INHIBITION-MALATE VS MALONATE 
82 
CONST. 
K= 
V= 
KII= 
l/KII= 
SIGMA= 
VARIANCE= 
VALUE 
3.5128D-02 
3.44750-01 
9.81730+00 
1.01860-01 
S.E. 
l.5771D-02 
5.78720-02 
3.10860+00 
3.16640-01 
3.2137040-02 
1.0327900-03 
Weight 
4.0207E+03 
2.9858E+02 
l.0349E-01 
O.OOOOE+OO 
UNCOMPETITIVE INHIBITION-OAA VS MALONATE 
CONST. 
K= 
V= 
KII= 
l/KII= 
SIGMA= 
VARIANCE= 
VALUE 
2.22090-02 
3.23100-01 
8.85360+00 
1.12950-01 
S.E. 
4.84050-03 
2.32130-02 
1.59070+00 
1.79660-01 
1.8575920-02 
3.4506480-04 
Weight 
4.2680E+04 
1.8558E+03 
3.9521E-01 
O.OOOOE+OO 
UNCOMPETITIVE INHIBITION-OAA VS KETOMALONATE 
CONST. 
K= 
V= 
KI.I= 
l/KII= 
SIGMA= 
VARIANCE= 
VALUE 
1.17560+00 
2.20390+00 
1.97090+00 
5.07380-01 
S.E. 
2.25880-01 
2.66860-01 
3.10030-01 
l.5731D-01 
4.1847710-02 
1.7512310-03 
UNCOMPETITIVE INHIBITION-NAD+ VS ATP 
83 
Weight 
1.9600E+Ol 
l.4042E+Ol 
1.0404E+Ol 
O.OOOOE+OO 
CONST. 
K= 
V= 
KIS= 
l/KIS= 
KII= 
SIGrvlA= 
VARIANCE= 
VALUE 
3.2998D-02 
3.3767D-01 
4.6630D+Ol 
2.1446D-02 
l.1286D+Ol 
S.E. 
l.3113D-02 
4.7337D-02 
l.3141D+02 
2.8181D+OO 
5.2122D+OO 
2.468139D-02 
6.091709D-04 
Weight 
5.8158E+03 
4.4627E+02 
5.7912E-05 
l.2592E-01 
3.6809E-02 
NONCOMPETITIVE INHIBITION-OAA VS rvlALONATE 
CONST. 
K= 
V= 
KIS= 
l/KIS= 
KII= 
SIGrvlA= 
VARIANCE= 
VALUE 
2.55530-02 
3.3568D-01 
1.19170+07 
8.39110-08 
7.3433D+OO 
S.E. 
7.55550-03 
3.2049D-02 
8.60240+12 
7.2184D+05 
2.1807D+OO 
1.8737330-02 
3.5108730-04 
Weight 
l.7518E+04 
9.7358E+02 
l.3513E-26 
l.9192E-12 
2.1028E-01 
NONCOMPETITIVE INHIBITION-OAA VS KETOrvlALONATE 
CONST. 
K= 
V= 
KIS= 
l/KIS= 
KII= 
SIGrvlA= 
VARIANCE= 
VALUE 
7.20660-01 
l.6997D+OO 
3.73290+00 
2.67890-01 
6.92390+00 
S.E. 
6.0979D-02 
7.3401D-02 
5.5681D-01 
l.4916D-01 
1.67830+00 
l.686188D-02 
2.8432290-04 
NONCOMPETITIVE INHIBITION-NAD+ VS ATP 
84 
Weight 
2.6893E+02 
l.8561E+02 
3.2254E+OO 
4.4943E+Ol 
3.5503E-01 
